372 related articles for article (PubMed ID: 8984849)
1. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
López Ibor JJ; Ayuso JL; Gutiérrez M; Guimon J; Herraiz ML; Chinchilla A; Ayuso JL; González Pinto A; Eguiluz I; Fernández A
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(4):165-72. PubMed ID: 8984849
[TBL] [Abstract][Full Text] [Related]
2. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
[TBL] [Abstract][Full Text] [Related]
3. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
4. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of risperidone and haloperidol treatment in schizophrenia.
Yen YC; Lung FW; Chong MY
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):285-90. PubMed ID: 14751424
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of risperidone in Asian patients with schizophrenia in Singapore.
Chong SA; Yap HL; Low BL; Choo CH; Chan AO; Wong KE; Mahendran R; Chee KT
Singapore Med J; 1999 Jan; 40(1):41-3. PubMed ID: 10361485
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
[TBL] [Abstract][Full Text] [Related]
9. Risperidone in acute and long-term therapy of schizophrenia--a clinical profile.
Pajonk FG
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):15-23. PubMed ID: 14687852
[TBL] [Abstract][Full Text] [Related]
10. Risperidone versus haloperidol in the treatment of chronic schizophrenic patients: a parallel group double-blind comparative trial.
Min SK; Rhee CS; Kim CE; Kang DY
Yonsei Med J; 1993 Jun; 34(2):179-90. PubMed ID: 7691017
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia.
Lin CH; Kuo CC; Chou LS; Chen YH; Chen CC; Huang KH; Lane HY
J Clin Psychopharmacol; 2010 Oct; 30(5):518-25. PubMed ID: 20814315
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
Ouyang WC; Hsu MC; Yeh IN; Kuo CC
Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
[TBL] [Abstract][Full Text] [Related]
13. Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients.
Lee SM; Chou YH; Li MH; Wan FJ; Yen MH
J Psychiatr Res; 2008 Mar; 42(4):328-35. PubMed ID: 17412363
[TBL] [Abstract][Full Text] [Related]
14. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
[TBL] [Abstract][Full Text] [Related]
15. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
17. Risperidone: clinical safety and efficacy in schizophrenia.
Borison RL; Pathiraja AP; Diamond BI; Meibach RC
Psychopharmacol Bull; 1992; 28(2):213-8. PubMed ID: 1381102
[TBL] [Abstract][Full Text] [Related]
18. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
Fang M; Chen H; Li LH; Wu R; Li Y; Liu L; Ye M; Huang J; Zhu S; Wang G; Zhang Q; Zheng H; Zhang L; Wang B; Zhou J; Zhao JP
Int Clin Psychopharmacol; 2012 Mar; 27(2):107-13. PubMed ID: 22233697
[TBL] [Abstract][Full Text] [Related]
19. Negative symptoms in schizophrenia: assessment of the effect of risperidone.
Schooler NR
J Clin Psychiatry; 1994 May; 55 Suppl():22-8. PubMed ID: 7520905
[TBL] [Abstract][Full Text] [Related]
20. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
Csernansky JG; Mahmoud R; Brenner R;
N Engl J Med; 2002 Jan; 346(1):16-22. PubMed ID: 11777998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]